Background: A large variety of foregut symptoms can occur in patients with
Introduction:
The selection of patients for antireflux surgery is as important as a good operative technique in reaching a satisfying therapeutic outcome for the patients. The variety of symptoms in patients with possible gastroesophageal reflux disease is substantial and have to be analysed prior to considering surgery (1-7). Especially the overlap to other diseases and in particular to functional disorders bears the risk of wrong diagnoses and misinterpretations (2, 4, 6, (8) (9) (10) (11) (12) (13) . In general, foregut symptoms such as epigastric pain, nausea, vomiting, belching, regurgitation, epigastric and/or retrosternal burning, swallowing discomfort or even respiratory symptoms such as hoarseness, chronic cough, pain in the throat, globus, pharyngeal, mouth and tongue burning can be related to Gastroesophageal Reflux Disease (GERD) as well as to several other diseases and pathologic conditions, which can be difficult to differentiate (1-13). A substantial part of these patients have symptoms from dyspepsia and somatoform disorders (4, (8) (9) (10) (11) (12) (13) .
GERD has a multifactorial pathophysiologic background and its clinical presentation shows a large variety of different symptoms including heartburn, regurgitation, epigastric pain, retrosternal pressure and pain, pharyngeal burning, hoarseness, chronic cough, nausea, vomiting and dysphagia (1, 3, 4, 5, 7, 14) . As shown in the past, heartburn and acid regurgitation are highly specific for GERD, when these are chief -4 - complaints of the patients (1,2,4,6,7,). However, these symptoms can show a broad overlap with other disorders such as functional dyspepsia, irritable bowel syndrome and somatoform disorders (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) .
Severe GERD can be objectified by endoscopy and by functional studies such as Impedance-pH-monitoring (4, 7, 24, 25) . But it remains a diagnostic dilemma in patients with borderline objective diagnostic findings in association with a large variety of unspecific foregut symptoms.
Somatization describes a situation, where in a given patient/person somatic complaints are present, which cannot be explained by pathophysiological and/or measurable findings (4, 9, 10, (26) (27) (28) (29) (30) (31) . Psychodiagnostic instruments are helpful in order to clarify the clinical situation and establish a diagnosis. Several tests are available to evaluate patients/persons with a suspicion of having a somatoform disorder (27) (28) (29) (30) (31) (32) (33) . Very often these patients have comorbid symptoms of depression and anxiety (33, 34) . In addition, somatoform disorders and anxiety can hamper the clinical assessment of patients (35, 36 ).
Due to this unclear diagnostic situation, these patients are often not adequately managed, since in many patients symptomatic therapy is started without further verification of the diagnostic background (37) (38) (39) . Furthermore, some patients receive insufficient drug therapy or inadequate life style advise for years, and sometimes even worse, they are referred to unjustified surgical therapy, after a long, refractory drug therapy.
Even more demanding for the diagnostic situation, the quality of life can be severely impaired in these patients and consequently the subjective experience of suffering can be demanding (7, 40, 41, 42) . Thus, there is a need for clearly defined criteria for -5 - therapeutic decision making based on sound reasoning and objective data.
Especially prior to gastric or antireflux surgery, a clear diagnostic picture with proven symptom-correlation to the underlying disease is mandatory. However, little is known about the relationship between GERD and somatoform tendencies.
Therefore, the purpose of this study is the evaluation of patients with a large variety of foregut symptoms, referred to a specialized surgical unit for possible laparoscopic antireflux surgery, regarding their pathophysiologic background and their relationship to GERD and/or aspects of somatization, based on control data from an unselected population.
Methods:
In this trial, the first step was a basic evaluation of the chosen instruments for symptom evaluation in a large unselected population of non-patient volunteers.
Symptom evaluation and Somatization screening were initiated both in volunteers and in patients with foregut symptoms in order to determine the possible differences.
Unselected population of non-patient volunteers (Normal control group)
For comparison, an unselected population of two villages was investigated, using questionnaires to determine the presence and the variety of their symptoms. In addition, a validated screening instrument for somatoform tendencies was applied.
For that purpose, the inhabitants of the villages were informed 3 weeks prior to the questionnaire about the project. Then the instruments for the assessment of symptoms and the evaluation of somatoform disorders (27) (28) (29) (30) (31) were distributed. Two days later the questionnaires were recollected and then evaluated. Inhabitants, who were known to be currently under medical treatment or who were seeking medical help, were excluded from the analysis.
Patients
Patients with foregut symptoms and heartburn, referred to a specialized referral center of gastrointestinal functional disease during a period of 4 years, were asked for their permission and were subsequently registered in the study, as permitted by our Institutional Review Board. They entered a defined prospective protocol of assessment and investigations. All patients received standardized questionnaires to assess all presenting symptoms, a validated screening test for somatoform disorders (27) (28) (29) (30) (31) similar to the normal control group.
Furthermore, the protocol consisted of documentation of their medical history, physical examination, upper gastrointestinal endoscopy, standard esophageal manometry, 24h-pH-monitoring, and other selectively used investigations such as 24h-bilirubine monitoring, gastric emptying scintigraphy and radiographic barium studies in order to determine the presence of GERD or other diseases, as described earlier (1,3,7).
Diagnostic Investigations:
Assessment of the variety of symptoms was performed by using the symptom-list as integrated in the instrument for the evaluation of somatoform disorders as established and validated by Rief (27) (28) (29) (30) (31) . The SOMS-Instrument was chosen, because it provides an extended list of symptoms, which serves the purposes of this study best, as it allows to screen for a general symptom load, which provides a -7 -sufficient number of non-gastrointestinal symptoms, to screen for a general symptom load in patients with a suspected or known gastrointestinal disorder.
The SOMS-instrument as "screening test for somatoform disorders" has been established and validated a few years ago (27) (28) (29) (30) (31) . Assessment for the presence of somatoform tendencies is performed by using this established instrument in the unselected healthy population and in all patients. The instrument SOMS (screening test for somatoform disorders) consists of 68 items, basically assessing the presence of the full variety of possible symptoms of the test-person.
In patients with somatoform disorders, some of these symptoms are quite frequently present (27, 28) . The instrument covers somatic symptoms that can occur in these patients with somatoform disorders without a clear physical explanation nor prove of explainable somatic changes. This questionnaire has extensively been validated and several methods of analysis are available (27) (28) (29) (30) (31) .
For the purpose of this study, the authors have chosen the analysis of the presence of symptoms and the presence of somatoform tendencies, using 53 items, which are basically a list of 53 symptoms (Table 1) . This symptom list is easy to apply for the investigated individuals. The symptom-list can serve as basis for the determination of all symptoms. Second, by counting the number of symptoms, present in a given patient without an explanation of the underlying cause, one can determine the Somatoform Symptom Index (SSI). The latter represents the level of probability for the presence of somatoform disorder in a given patient (27) . This analysis is documented in the original manual and shows for normal values a SSI of 5,1. In the original manual (SOMS: Screening für Somatoforme Störungen) by Rief, the borderline value towards 99 percentile probability for the presence of somatoform disorders is a SSI of 17 symptoms (27) .
All patients underwent upper gastrointestinal endoscopy, esophageal manometry, and esophageal 24-h-pH-monitoring. All data were gathered and documented prospectively. During endoscopy, the severity of esophagitis was graded according to the classification of Savary-Miller and the present size of the hiatus hernia was measured.
Standard esophageal manometry was carried out using an 8-lumen, waterperfused manometry catheter on the reclining, fasting patient. The position, pressure, and length of the lower esophageal sphincter were determined with the pull-through manometry, using these measurements for the correct positioning of the pH-probes 5cm above the upper boarder of the lower esophageal sphincter.
24h-pH-monitoring was applied in standard technique using for analysis the
DeMeester-reflux-score criteria (1). This implemented a borderline between physiologic and pathologic esophageal acid exposure, if the score reached a value of 14,7. Seven days prior to the examination all medications affecting motility and acid suppression were stopped.
Analyses
Different analyses were performed on the generated data. A first analysis was made by creating an overview on the presence and variety of different symptoms in the unselected control population (symptom-analysis 1), in all patients with foregut symptoms, separated in those without pathologic reflux (symptom-analysis 2) as well as in patients with documented GERD (symptom-analysis 3).
Secondly, the probability for the presence of somatoform tendencies was evaluated in the unselected control population, in the patient-group with foregut symptoms and in the documented GERD-patients in order to determine the differences.
Since the size of the investigated populations were rather large, the students T-test was used for the simple group comparisons. If multiple comparisons were performed such as in the analysis of symptoms, alpha-level was adjusted accordingly (for n=53 items in the SOMS manual adjusted p=0.00094). For the comparison of the number of patients with positive and negative DeMeester score compared to an SSI≤17 or >17 (contingency table) a Chi-square test was conducted. All analyses were carried out with SPSS.
Results: Characteristics of Control group:
The unselected control-group consisted of 267 healthy inhabitants of two villages.
There were 127 males and 140 females. The mean age was 44 years (Standard Deviation 1,551, range 18-84). This group of volunteers represents a country based population.
Patient`s characteristics
In a 4 year period 750 patients with foregut symptoms and heartburn were prospectively included in this study. Patients had a mean age of 49 years (16-89).
There were 305 females and 445 males. The prospectively documented data showed -10 - at time of evaluation for this study a partial lack of data in 99 data-sets, leaving 651 complete patient data-sets (foregut-symptom group) for detailed analysis.
The patients of the foregut-symptom group (n=651) had a mean age of 49 years (18 
Comparison between patients and the control group:
The classic foregut symptoms such as epigastric pain, belly pain, fullness and belching are more frequently present compared to healthy volunteers. Belly pain is present in 70 % of patients, fullness in 67%, belching in 72 %, hick-ups and burning in 69%, and food intolerance in 60%.
The comparison between the symptom presence in unselected volunteers and in patients with foregut symptoms demonstrate significant differences for several symptoms. The most important differences are shown in Table 2 . This indicates that there was no statistical connection between acid exposure and a measure for somatoform tendencies, the SSI in a group of patients with GERD, and thus a high symptom load.
In summary, the results of this study show a remarkable variety of symptoms in healthy volunteers and in patients seeking help because of their foregut symptoms.
There is no major significant difference in the symptom-spectrum in patients with foregut symptoms, whether they have a proven pathologic acid exposure from GERD or not.
The probability for the risk of somatization as indicated by a SSI > 17 was as high as 5,6 % in the unselected population of non-patient volunteers. In patients with foregut symptoms, the probability for the presence of somatoform tendencies was approximately 20 %, independent whether these patients had a documented GERD or a normal esophageal acid exposure. Furthermore a high risk for somatization can be likewise present in patients with foregut symptoms with and without proven GERD.
Discussion:
This work was stimulated by the diagnostic dilemma regarding patients with a large variety of foregut symptoms, seeking for medical help and possible antireflux surgery However, there are controversial reports regarding the correlation between functional testing and symptoms, which makes precise diagnosis difficult based on symptoms (2, 4, 7, 17, 20, (37) (38) (39) . However, the presence of heartburn and regurgitation in patients with GERD does have a positive prognostic value regarding the outcome of a potential antireflux operation (43) .
Regurgitation is also one of the most important symptoms in GERD with a prevalence of 33 -86% (1,2,3,4,7,44 ). Epigastric pain is present in patients with foregut symptoms in 70 %, in those with documented pathologic acid reflux in 12 -67 %. The overlap with dyspepsia and somatoform disorders is large (1-20).
-15 -Extraesophageal symptoms such as cough, hoarsness, globus and breathing problems can be associated with syndromes such as Reflux cough syndrome and with laryngitis and asthma (4, 7, (45) (46) (47) (48) (49) (50) (51) (52) .
In this study, the diagnosis of GERD in the "foregut patients" was established based on the traditional diagnostic workup with clinical evaluation, endoscopy and functional testing including ph-monitoring to determine the esophageal acid exposure (1,3) . This was done with intention to verify undoubtedly the presence or absence of the disease. One could argue that esophagitis-positive is enough proof of GERD and no further diagnostic testing is necessary (6) . The diagnostic value of the presence or absence or the grading of esophagitis is limited by the unknown effect of protonpump-inhibitor therapy, which can not be assessed accurately in such a patient population. The authors felt that for the purpose of this study, a clear separation criterion was needed, which could be best served by the acid exposure as measured by 24h-pH-monitoring. This would allow for a sharp discrimination line between physiologic and pathologic acid exposure (1,3,7) .
The authors have chosen the SOMS instrument of Rief, because this instrument is validated extensively and its applicability is possible in all patients (27) (28) (29) (30) (31) . The SOMS instrument covers a large variety of symptoms, including also physical symptoms, which many patients with foregut problems do have. The latter is important to have a common pool of symptoms covering the aspect of somatization and GERD. For the comparison of the data with GERD-patients the authors wanted to include as many symptoms in the total assessment as possible to make sure that all possible reflux associated symptoms would be integrated in the analysis.
A central criterion for the diagnosis of somatoform disorders has been the exclusion of a somatic disorder, that can explain the symptom pattern (27) (28) (29) 36 ). However, this has been a major challenge in the diagnostics of somatoform disorders, since patients can very well have pathological findings, which, however, do not explain the extent of their symptom load or the suffering associated with it. Therefore, this demand has been substantially weakened in the very recent Diagnostic and Statistical Manual of Mental disorders (DSM-5) and the syndrome has recently been renamed to "somatic symptom disorder" (36). However, since the data collection and the whole rationale of the study is based of the former definition of the DSM IV, the terminology of somatoform disorder can be used.
Nonetheless, the current redefinition sheds light on the implicit challenge to establish an appropriate procedure with the goal to achieve a good diagnostic process, which takes all aspects of the patients suffering into account: the "objective" pathophysiological measures, and the subjective suffering associated with the symptom load. Thus, the establishment of a precise diagnosis based on symptom analysis in patients with foregut symptoms with the aim to differentiate between GERD and functional dyspepsia, while at the same time taking the aspect of somatization into account, is challenging (8, 16, 17, 20) .
If the symptom load in GERD was exclusively related to pathologic acid exposure, then it could have been expected that patients with high symptom load and a negative DeMeester score would show a higher risk for somatization. However, this was not the case.
The data suggests that there is no correlation between the symptoms and the objective data of esophageal acid exposure as well as the tendency for a somatoform -17 - disorder, which irritates on first sight. However, this was shown in the statistical comparison with parametric tests using large groups. In addition, also nonparametric tests (Spearman-Rho) were performed indicating that both showed no significant correlation. Considering the size of the volunteer population and the patient population, it can be concluded that indeed the presence of symptoms does not correlate to the objective functional data.
In conclusion, these findings do imply that in the case of GERD, somatoform tendencies as indicated by a SSI > 17 can well be associated with pathological reflux.
These findings emphasize the usefulness of the redefinition of the concept of somatoform disorders, as expressed in the DSM-5 (27, 36) . Indirectly, this present study and its control group reproduces and thus confirms the original data published in the SOMS-manual by Rief, in which they have listed normal percentage values for different percentiles (27) . The value of more than 17 symptoms for the SSI reflects a 99% probability of the presence of somatoform disorder in the original validation, which corresponds exactly to the result of the control population in this study.
A number of studies have been performed with similar intention (10, 32, 36, 37, 38, (53) (54) (55) (56) . Other instruments are the symptom-check-list SCL-90-R and the HypochondrieScale MMPI, which evaluate fewer symptoms and are therefore more restricted (10, 27, 53, 54) . Another instrument is the "Othmer and de Souza Screening Test" for somatoform disorders (55, 56, 57) . The latter has been also criticized for the limited number of symptoms. With the SCAN-Test (Schedules for Clinical Assessment in Neuropsychiatry) 19% of patients within an investigated population was detected with signs for somatoform disorders, which reflects a similar portion of patients as in our current study population (57) .
In a study from Australia, 340 family doctors were involved, using the Kessler Psychological Distress Scale, the Whiteley Index and the 15-item Patient Health Questionaire (PHQ-15) on their patients (10) . In 10507 patients, 18,5 % were identified as "somatizer", thus suffering from somatoform tendencies.
Again, it is quite interesting that the portion of patients with signs of somatoform disorders, is reported in different studies at the level around 20% in several patient populations with different disease entities. As detected in this study with GERD patients, the portion of patients with signs of somatization was also around 20 %.
Conclusions:
In conclusion, the results of this study show a number important facts:
There is a remarkable symptom load and variety in patients with foregut symptoms and more specific in patients with documented GERD. The portion of patients, who are at risk for a somatisation disorder was around 20 %. There is no difference in the risk for somatization between patients with foregut symptoms and those with documented GERD.
There is also a substantial variety of symptoms in an unselected population of nonpatient volunteers. A reasonably high proportion of these study participants (5,6 %) would be classified as being at risk for a somatoform disorder, if they did not suffer from a confirmed somatic disease.
Based on these findings, our study has important clinical implications for the future, which can be concluded as follows: Symptoms are not a reliable guide in these functional disorders to verify the diagnosis alone, especially in GERD. Functional testing is essential for a precise diagnosis or exclusion of GERD and subsequent -19 - therapeutic decision making. If in the diagnostic process, a risk for a somatoform symptom disorder is perceived, a further clinical psycho-diagnostic evaluation is recommended. An accurate process of therapeutic decision making especially prior to antireflux surgery in all patients with multiple and complex foregut symptoms, requires not only a thorough investigation of the somatic pathophysiology, but in addition an awareness of the mental and emotional challenges, many patients with a high symptom load have. These aspects are of utter importance for the clinical prospects of the individual patient and should also have an impact on patient informed consent prior to the decision making for any long term treatment and antireflux surgery.
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